KALA vs STT · $54.3M cap vs P/E 17, rev $7.84B
Kala Pharmaceuticals Inc (KALA) versus State Street Corp (STT) — a side-by-side from cached financials, not a winner call.
Kala Pharmaceuticals Inc (KALA) is a biotechnology company listed on NASDAQ.
State Street Corp (STT) is a asset management company listed on US.
Latest reported KALA revenue for 2025-12-31 was $0. Net income was -$27.0M. KALA currently screens at market cap $54.3M.
Latest reported STT revenue for 2026-06-30 was $7.84B. Net income was $1.85B. STT currently screens at market cap $45.02B and trailing P/E 16.5.
KALA currently screens at market cap $54.3M. STT currently screens at market cap $45.02B and trailing P/E 16.5.
Not investment advice. Open the KALA and STT stock pages for the full models.
Not investment advice.